Literature DB >> 31779467

Coronary Microvascular Dysfunction, Left Ventricular Remodeling, and Clinical Outcomes in Patients With Chronic Kidney Impairment.

Navkaranbir S Bajaj1,2, Amitoj Singh1, Wunan Zhou1, Ankur Gupta1, Kana Fujikura1, Christina Byrne1, Hendrik J Harms1, Michael T Osborne3, Paco Bravo1, Efstathia Andrikopolou1, Sanjay Divakaran1, Courtney F Bibbo1, Jon Hainer1, Hicham Skali1, Viviany Taqueti1, Michael Steigner1, Sharmila Dorbala1, David M Charytan4, Sumanth D Prabhu2, Ron Blankstein1, Rahul C Deo1, Scott D Solomon1, Marcelo F Di Carli1.   

Abstract

BACKGROUND: Cardiac dysfunction and cardiovascular events are prevalent among patients with chronic kidney disease without overt obstructive coronary artery disease, but the mechanisms remain poorly understood. Coronary microvascular dysfunction has been proposed as a link between abnormal renal function and impairment of cardiac function and cardiovascular events. We aimed to investigate the relations between chronic kidney disease, coronary microvascular dysfunction, cardiac dysfunction, and adverse cardiovascular outcomes.
METHODS: Patients undergoing cardiac stress positron emission tomography, echocardiogram, and renal function ascertainment at Brigham and Women's Hospital were studied longitudinally. Patients free of overt coronary (summed stress score <3 and without a history of ischemic heart disease), valvular, and end-organ disease were followed up for the adverse composite outcome of death or hospitalization for myocardial infarction or heart failure. Coronary flow reserve (CFR) was determined from positron emission tomography. Echocardiograms were used to measure cardiac mechanics: diastolic (lateral and septal E/e') and systolic (global longitudinal, radial, and circumferential strain). Image analyses and event adjudication were blinded. The associations between estimated glomerular filtration rate (eGFR), CFR, diastolic and systolic indices, and adverse cardiovascular outcomes were assessed in adjusted models and mediation analyses.
RESULTS: Of the 352 patients (median age, 65 years; 63% female; 22% black) studied, 35% had an eGFR <60 mL·min-1·1.73 m-2, a median left ventricular ejection fraction of 62%, and a median CFR of 1.8. eGFR and CFR were associated with diastolic and systolic indices, as well as future cardiovascular events (all P<0.05). In multivariable models, CFR, but not eGFR, was independently associated with cardiac mechanics and cardiovascular events. The associations between eGFR, cardiac mechanics, and cardiovascular events were partly mediated via CFR.
CONCLUSIONS: Coronary microvascular dysfunction, but not eGFR, was independently associated with abnormal cardiac mechanics and an increased risk of cardiovascular events. Coronary microvascular dysfunction may mediate the effect of chronic kidney disease on abnormal cardiac function and cardiovascular events in those without overt coronary artery disease.

Entities:  

Keywords:  chronic; renal insufficiency

Mesh:

Year:  2019        PMID: 31779467      PMCID: PMC7117866          DOI: 10.1161/CIRCULATIONAHA.119.043916

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  44 in total

1.  Improved cardiac risk assessment with noninvasive measures of coronary flow reserve.

Authors:  Venkatesh L Murthy; Masanao Naya; Courtney R Foster; Jon Hainer; Mariya Gaber; Gilda Di Carli; Ron Blankstein; Sharmila Dorbala; Arkadiusz Sitek; Michael J Pencina; Marcelo F Di Carli
Journal:  Circulation       Date:  2011-10-17       Impact factor: 29.690

2.  Current and evolving echocardiographic techniques for the quantitative evaluation of cardiac mechanics: ASE/EAE consensus statement on methodology and indications endorsed by the Japanese Society of Echocardiography.

Authors:  Victor Mor-Avi; Roberto M Lang; Luigi P Badano; Marek Belohlavek; Nuno Miguel Cardim; Geneviève Derumeaux; Maurizio Galderisi; Thomas Marwick; Sherif F Nagueh; Partho P Sengupta; Rosa Sicari; Otto A Smiseth; Beverly Smulevitz; Masaaki Takeuchi; James D Thomas; Mani Vannan; Jens-Uwe Voigt; José Luis Zamorano
Journal:  J Am Soc Echocardiogr       Date:  2011-03       Impact factor: 5.251

3.  Global coronary flow reserve is associated with adverse cardiovascular events independently of luminal angiographic severity and modifies the effect of early revascularization.

Authors:  Viviany R Taqueti; Rory Hachamovitch; Venkatesh L Murthy; Masanao Naya; Courtney R Foster; Jon Hainer; Sharmila Dorbala; Ron Blankstein; Marcelo F Di Carli
Journal:  Circulation       Date:  2014-11-16       Impact factor: 29.690

4.  Definition and classification of chronic kidney disease: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO).

Authors:  Andrew S Levey; Kai-Uwe Eckardt; Yusuke Tsukamoto; Adeera Levin; Josef Coresh; Jerome Rossert; Dick De Zeeuw; Thomas H Hostetter; Norbert Lameire; Garabed Eknoyan
Journal:  Kidney Int       Date:  2005-06       Impact factor: 10.612

Review 5.  Is left ventricular hypertrophy a modifiable risk factor in end-stage renal disease.

Authors:  David Charytan
Journal:  Curr Opin Nephrol Hypertens       Date:  2014-11       Impact factor: 2.894

Review 6.  Diagnostic accuracy of stress myocardial perfusion imaging compared to invasive coronary angiography with fractional flow reserve meta-analysis.

Authors:  Richard A P Takx; Björn A Blomberg; Hamza El Aidi; Jesse Habets; Pim A de Jong; Eike Nagel; Udo Hoffmann; Tim Leiner
Journal:  Circ Cardiovasc Imaging       Date:  2015-01       Impact factor: 7.792

7.  Prognostic Value of Coronary Flow Reserve in Patients with Dialysis-Dependent ESRD.

Authors:  Nishant R Shah; David M Charytan; Venkatesh L Murthy; Hicham Skali Lami; Vikas Veeranna; Michael K Cheezum; Viviany R Taqueti; Takashi Kato; Courtney R Foster; Jon Hainer; Mariya Gaber; Josh Klein; Sharmila Dorbala; Ron Blankstein; Marcelo F Di Carli
Journal:  J Am Soc Nephrol       Date:  2015-10-12       Impact factor: 10.121

8.  A new equation to estimate glomerular filtration rate.

Authors:  Andrew S Levey; Lesley A Stevens; Christopher H Schmid; Yaping Lucy Zhang; Alejandro F Castro; Harold I Feldman; John W Kusek; Paul Eggers; Frederick Van Lente; Tom Greene; Josef Coresh
Journal:  Ann Intern Med       Date:  2009-05-05       Impact factor: 25.391

9.  Evaluation of coronary microvascular function in patients with end-stage renal disease, and renal allograft recipients.

Authors:  Huseyin Bozbas; Bahar Pirat; Saadet Demirtas; Vahide Simşek; Aylin Yildirir; Elif Sade; Burak Sayin; Siren Sezer; Hamdi Karakayali; Haldun Muderrisoglu
Journal:  Atherosclerosis       Date:  2008-05-04       Impact factor: 5.162

10.  A novel feature-tracking echocardiographic method for the quantitation of regional myocardial function: validation in an animal model of ischemia-reperfusion.

Authors:  Bahar Pirat; Dirar S Khoury; Craig J Hartley; Les Tiller; Liyun Rao; Daryl G Schulz; Sherif F Nagueh; William A Zoghbi
Journal:  J Am Coll Cardiol       Date:  2008-02-12       Impact factor: 24.094

View more
  19 in total

1.  The legacy of ISCHEMIA.

Authors:  Umberto Ianni; Francesco Radico; Fabrizio Ricci; Matteo Perfetti; Federico Archilletti; Giulia Renda; Nicola Maddestra; Sabina Gallina; Marco Zimarino
Journal:  Cardiol J       Date:  2020       Impact factor: 2.737

2.  Low coronary flow relative to myocardial mass predicts heart failure in symptomatic hypertensive patients with no obstructive coronary artery disease.

Authors:  Jenifer M Brown; Wunan Zhou; Brittany Weber; Sanjay Divakaran; Leanne Barrett; Courtney F Bibbo; Jon Hainer; Viviany R Taqueti; Sharmila Dorbala; Ron Blankstein; Marcelo F Di Carli
Journal:  Eur Heart J       Date:  2022-09-14       Impact factor: 35.855

3.  Call on the reserve: Coronary vasomotor dysfunction is a potential biomarker of cardiovascular risk in patients with breast cancer.

Authors:  Michael T Osborne; Simran Grewal; Tomas G Neilan
Journal:  J Nucl Cardiol       Date:  2021-12-14       Impact factor: 3.872

4.  Coronary vasomotor dysfunction portends worse outcomes in patients with breast cancer.

Authors:  Sanjay Divakaran; Jesse P Caron; Wunan Zhou; Jon Hainer; Courtney F Bibbo; Hicham Skali; Viviany R Taqueti; Sharmila Dorbala; Ron Blankstein; John D Groarke; Anju Nohria; Marcelo F Di Carli
Journal:  J Nucl Cardiol       Date:  2021-11-24       Impact factor: 3.872

Review 5.  Microvascular Dysfunction as a Systemic Disease: A Review of the Evidence.

Authors:  Daniel S Feuer; Eileen M Handberg; Borna Mehrad; Janet Wei; C Noel Bairey Merz; Carl J Pepine; Ellen C Keeley
Journal:  Am J Med       Date:  2022-04-23       Impact factor: 5.928

6.  Echocardiographic strain analysis reflects impaired ventricular function in youth with pediatric-onset systemic lupus erythematosus.

Authors:  Joyce C Chang; Yan Wang; Rui Xiao; Anysia Fedec; Kevin E Meyers; Craig Tinker; Shobha S Natarajan; Andrea M Knight; Pamela F Weiss; Laura Mercer-Rosa
Journal:  Echocardiography       Date:  2020-10-03       Impact factor: 1.724

7.  Impaired Coronary Vasodilator Reserve and Adverse Prognosis in Patients With Systemic Inflammatory Disorders.

Authors:  Brittany N Weber; Emma Stevens; Lourdes M Perez-Chada; Jenifer M Brown; Sanjay Divakaran; Camden Bay; Courtney Bibbo; Jon Hainer; Sharmila Dorbala; Ron Blankstein; Viviany R Taqueti; Joseph F Merola; Elena Massarotti; Karen Costenbader; Katherine Liao; Marcelo F Di Carli
Journal:  JACC Cardiovasc Imaging       Date:  2021-03-17

8.  Perturbations in myocardial perfusion and oxygen balance in swine with multiple risk factors: a novel model of ischemia and no obstructive coronary artery disease.

Authors:  Jens van de Wouw; Oana Sorop; Ruben W A van Drie; Richard W B van Duin; Isabel T N Nguyen; Jaap A Joles; Marianne C Verhaar; Daphne Merkus; Dirk J Duncker
Journal:  Basic Res Cardiol       Date:  2020-02-25       Impact factor: 17.165

Review 9.  Novel insight into perirenal adipose tissue: A neglected adipose depot linking cardiovascular and chronic kidney disease.

Authors:  Na Huang; En-Wen Mao; Ning-Ning Hou; Yong-Ping Liu; Fang Han; Xiao-Dong Sun
Journal:  World J Diabetes       Date:  2020-04-15

10.  Hypertensive coronary microvascular dysfunction: a subclinical marker of end organ damage and heart failure.

Authors:  Wunan Zhou; Jenifer M Brown; Navkaranbir S Bajaj; Alvin Chandra; Sanjay Divakaran; Brittany Weber; Courtney F Bibbo; Jon Hainer; Viviany R Taqueti; Sharmila Dorbala; Ron Blankstein; Dale Adler; Patrick O'Gara; Marcelo F Di Carli
Journal:  Eur Heart J       Date:  2020-07-01       Impact factor: 35.855

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.